Global and United States Homocystinuria Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Homocystinuria Market
This report focuses on global and United States Homocystinuria market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Homocystinuria market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Diagnosis accounting for % of the Homocystinuria global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Homocystinuria market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Homocystinuria Scope and Market Size
Homocystinuria market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Homocystinuria market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Homocystinuria market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Diagnosis
    Treatment

Segment by Application
    Hospitals
    Clinics
    Diagnostic and Imaging Laboratories
    Academic and Research Institutes
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    BASF SE
    HUAZHONG PHARMACEUTICAL Co. Ltd.
    Pfizer Inc.
    MYLAN N.V.
    Aeglea BioTherapeutics
    Amino GMBH
    KAO Corporation
    DSM Corporation
    Orphan Technologies
    Fresenius Kabi AG

 1 Study Coverage
    1.1 Homocystinuria Revenue in Homocystinuria Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Homocystinuria Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Homocystinuria Market Size for the Year 2017-2028
        1.2.2 Global Homocystinuria Market Size for the Year 2017-2028
    1.3 Homocystinuria Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Homocystinuria in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Homocystinuria Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Homocystinuria Market Dynamics
        1.4.1 Homocystinuria Industry Trends
        1.4.2 Homocystinuria Market Drivers
        1.4.3 Homocystinuria Market Challenges
        1.4.4 Homocystinuria Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Homocystinuria by Type
    2.1 Homocystinuria Market Segment by Type
        2.1.1 Diagnosis
        2.1.2 Treatment
    2.2 Global Homocystinuria Market Size by Type (2017, 2022 & 2028)
    2.3 Global Homocystinuria Market Size by Type (2017-2028)
    2.4 United States Homocystinuria Market Size by Type (2017, 2022 & 2028)
    2.5 United States Homocystinuria Market Size by Type (2017-2028)

 3 Homocystinuria by Application
    3.1 Homocystinuria Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Diagnostic and Imaging Laboratories
        3.1.4 Academic and Research Institutes
        3.1.5 Others
    3.2 Global Homocystinuria Market Size by Application (2017, 2022 & 2028)
    3.3 Global Homocystinuria Market Size by Application (2017-2028)
    3.4 United States Homocystinuria Market Size by Application (2017, 2022 & 2028)
    3.5 United States Homocystinuria Market Size by Application (2017-2028)

 4 Global Homocystinuria Competitor Landscape by Company
    4.1 Global Homocystinuria Market Size by Company
        4.1.1 Top Global Homocystinuria Companies Ranked by Revenue (2021)
        4.1.2 Global Homocystinuria Revenue by Player (2017-2022)
    4.2 Global Homocystinuria Concentration Ratio (CR)
        4.2.1 Homocystinuria Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Homocystinuria in 2021
        4.2.3 Global Homocystinuria Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Homocystinuria Headquarters, Revenue in Homocystinuria Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Homocystinuria Headquarters and Area Served
        4.3.2 Global Homocystinuria Companies Revenue in Homocystinuria Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Homocystinuria Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Homocystinuria Market Size by Company
        4.5.1 Top Homocystinuria Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Homocystinuria Revenue by Players (2020, 2021 & 2022)

 5 Global Homocystinuria Market Size by Region
    5.1 Global Homocystinuria Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Homocystinuria Market Size by Region (2017-2028)
        5.2.1 Global Homocystinuria Market Size by Region: 2017-2022
        5.2.2 Global Homocystinuria Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Homocystinuria Market Size YoY Growth 2017-2028
        6.1.2 North America Homocystinuria Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Homocystinuria Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Homocystinuria Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Homocystinuria Market Size YoY Growth 2017-2028
        6.3.2 Europe Homocystinuria Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Homocystinuria Market Size YoY Growth 2017-2028
        6.4.2 Latin America Homocystinuria Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Homocystinuria Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Homocystinuria Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 BASF SE
        7.1.1 BASF SE Company Details
        7.1.2 BASF SE Business Overview
        7.1.3 BASF SE Homocystinuria Introduction
        7.1.4 BASF SE Revenue in Homocystinuria Business (2017-2022)
        7.1.5 BASF SE Recent Development
    7.2 HUAZHONG PHARMACEUTICAL Co. Ltd.
        7.2.1 HUAZHONG PHARMACEUTICAL Co. Ltd. Company Details
        7.2.2 HUAZHONG PHARMACEUTICAL Co. Ltd. Business Overview
        7.2.3 HUAZHONG PHARMACEUTICAL Co. Ltd. Homocystinuria Introduction
        7.2.4 HUAZHONG PHARMACEUTICAL Co. Ltd. Revenue in Homocystinuria Business (2017-2022)
        7.2.5 HUAZHONG PHARMACEUTICAL Co. Ltd. Recent Development
    7.3 Pfizer Inc.
        7.3.1 Pfizer Inc. Company Details
        7.3.2 Pfizer Inc. Business Overview
        7.3.3 Pfizer Inc. Homocystinuria Introduction
        7.3.4 Pfizer Inc. Revenue in Homocystinuria Business (2017-2022)
        7.3.5 Pfizer Inc. Recent Development
    7.4 MYLAN N.V.
        7.4.1 MYLAN N.V. Company Details
        7.4.2 MYLAN N.V. Business Overview
        7.4.3 MYLAN N.V. Homocystinuria Introduction
        7.4.4 MYLAN N.V. Revenue in Homocystinuria Business (2017-2022)
        7.4.5 MYLAN N.V. Recent Development
    7.5 Aeglea BioTherapeutics
        7.5.1 Aeglea BioTherapeutics Company Details
        7.5.2 Aeglea BioTherapeutics Business Overview
        7.5.3 Aeglea BioTherapeutics Homocystinuria Introduction
        7.5.4 Aeglea BioTherapeutics Revenue in Homocystinuria Business (2017-2022)
        7.5.5 Aeglea BioTherapeutics Recent Development
    7.6 Amino GMBH
        7.6.1 Amino GMBH Company Details
        7.6.2 Amino GMBH Business Overview
        7.6.3 Amino GMBH Homocystinuria Introduction
        7.6.4 Amino GMBH Revenue in Homocystinuria Business (2017-2022)
        7.6.5 Amino GMBH Recent Development
    7.7 KAO Corporation
        7.7.1 KAO Corporation Company Details
        7.7.2 KAO Corporation Business Overview
        7.7.3 KAO Corporation Homocystinuria Introduction
        7.7.4 KAO Corporation Revenue in Homocystinuria Business (2017-2022)
        7.7.5 KAO Corporation Recent Development
    7.8 DSM Corporation
        7.8.1 DSM Corporation Company Details
        7.8.2 DSM Corporation Business Overview
        7.8.3 DSM Corporation Homocystinuria Introduction
        7.8.4 DSM Corporation Revenue in Homocystinuria Business (2017-2022)
        7.8.5 DSM Corporation Recent Development
    7.9 Orphan Technologies
        7.9.1 Orphan Technologies Company Details
        7.9.2 Orphan Technologies Business Overview
        7.9.3 Orphan Technologies Homocystinuria Introduction
        7.9.4 Orphan Technologies Revenue in Homocystinuria Business (2017-2022)
        7.9.5 Orphan Technologies Recent Development
    7.10 Fresenius Kabi AG
        7.10.1 Fresenius Kabi AG Company Details
        7.10.2 Fresenius Kabi AG Business Overview
        7.10.3 Fresenius Kabi AG Homocystinuria Introduction
        7.10.4 Fresenius Kabi AG Revenue in Homocystinuria Business (2017-2022)
        7.10.5 Fresenius Kabi AG Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Homocystinuria Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Homocystinuria Market Trends
    Table 3. Homocystinuria Market Drivers
    Table 4. Homocystinuria Market Challenges
    Table 5. Homocystinuria Market Restraints
    Table 6. Global Homocystinuria Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Homocystinuria Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Homocystinuria Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Homocystinuria Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Homocystinuria Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Homocystinuria Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Homocystinuria Revenue Share by Player, 2017-2022
    Table 13. Global Homocystinuria Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Homocystinuria by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Homocystinuria as of 2021)
    Table 15. Top Players of Homocystinuria in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Homocystinuria Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Homocystinuria Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Homocystinuria Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Homocystinuria Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Homocystinuria Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Homocystinuria Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Homocystinuria Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Homocystinuria Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Homocystinuria Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Homocystinuria Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Homocystinuria Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Homocystinuria Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Homocystinuria Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. BASF SE Company Details
    Table 31. BASF SE Business Overview
    Table 32. BASF SE Homocystinuria Product
    Table 33. BASF SE Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
    Table 34. BASF SE Recent Development
    Table 35. HUAZHONG PHARMACEUTICAL Co. Ltd. Company Details
    Table 36. HUAZHONG PHARMACEUTICAL Co. Ltd. Business Overview
    Table 37. HUAZHONG PHARMACEUTICAL Co. Ltd. Homocystinuria Product
    Table 38. HUAZHONG PHARMACEUTICAL Co. Ltd. Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
    Table 39. HUAZHONG PHARMACEUTICAL Co. Ltd. Recent Development
    Table 40. Pfizer Inc. Company Details
    Table 41. Pfizer Inc. Business Overview
    Table 42. Pfizer Inc. Homocystinuria Product
    Table 43. Pfizer Inc. Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
    Table 44. Pfizer Inc. Recent Development
    Table 45. MYLAN N.V. Company Details
    Table 46. MYLAN N.V. Business Overview
    Table 47. MYLAN N.V. Homocystinuria Product
    Table 48. MYLAN N.V. Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
    Table 49. MYLAN N.V. Recent Development
    Table 50. Aeglea BioTherapeutics Company Details
    Table 51. Aeglea BioTherapeutics Business Overview
    Table 52. Aeglea BioTherapeutics Homocystinuria Product
    Table 53. Aeglea BioTherapeutics Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
    Table 54. Aeglea BioTherapeutics Recent Development
    Table 55. Amino GMBH Company Details
    Table 56. Amino GMBH Business Overview
    Table 57. Amino GMBH Homocystinuria Product
    Table 58. Amino GMBH Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
    Table 59. Amino GMBH Recent Development
    Table 60. KAO Corporation Company Details
    Table 61. KAO Corporation Business Overview
    Table 62. KAO Corporation Homocystinuria Product
    Table 63. KAO Corporation Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
    Table 64. KAO Corporation Recent Development
    Table 65. DSM Corporation Company Details
    Table 66. DSM Corporation Business Overview
    Table 67. DSM Corporation Homocystinuria Product
    Table 68. DSM Corporation Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
    Table 69. DSM Corporation Recent Development
    Table 70. Orphan Technologies Company Details
    Table 71. Orphan Technologies Business Overview
    Table 72. Orphan Technologies Homocystinuria Product
    Table 73. Orphan Technologies Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
    Table 74. Orphan Technologies Recent Development
    Table 75. Fresenius Kabi AG Company Details
    Table 76. Fresenius Kabi AG Business Overview
    Table 77. Fresenius Kabi AG Homocystinuria Product
    Table 78. Fresenius Kabi AG Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
    Table 79. Fresenius Kabi AG Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Homocystinuria Product Picture
    Figure 2. Global Homocystinuria Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Homocystinuria Market Size 2017-2028 (US$ Million)
    Figure 4. United States Homocystinuria Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Homocystinuria Market Size 2017-2028 (US$ Million)
    Figure 6. United States Homocystinuria Market Share in Global 2017-2028
    Figure 7. Homocystinuria Report Years Considered
    Figure 8. Product Picture of Diagnosis
    Figure 9. Product Picture of Treatment
    Figure 10. Global Homocystinuria Market Share by Type in 2022 & 2028
    Figure 11. Global Homocystinuria Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Homocystinuria Market Share by Type (2017-2028)
    Figure 13. United States Homocystinuria Market Share by Type in 2022 & 2028
    Figure 14. United States Homocystinuria Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Homocystinuria Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Clinics
    Figure 18. Product Picture of Diagnostic and Imaging Laboratories
    Figure 19. Product Picture of Academic and Research Institutes
    Figure 20. Product Picture of Others
    Figure 21. Global Homocystinuria Market Share by Application in 2022 & 2028
    Figure 22. Global Homocystinuria Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Homocystinuria Market Share by Application (2017-2028)
    Figure 24. United States Homocystinuria Market Share by Application in 2022 & 2028
    Figure 25. United States Homocystinuria Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Homocystinuria Market Share by Application (2017-2028)
    Figure 27. North America Homocystinuria Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. United States Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Homocystinuria Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Homocystinuria Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. China Taiwan Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Homocystinuria Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Colombia Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Homocystinuria Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. UAE Homocystinuria Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. BASF SE Revenue Growth Rate in Homocystinuria Business (2017-2022)
    Figure 56. HUAZHONG PHARMACEUTICAL Co. Ltd. Revenue Growth Rate in Homocystinuria Business (2017-2022)
    Figure 57. Pfizer Inc. Revenue Growth Rate in Homocystinuria Business (2017-2022)
    Figure 58. MYLAN N.V. Revenue Growth Rate in Homocystinuria Business (2017-2022)
    Figure 59. Aeglea BioTherapeutics Revenue Growth Rate in Homocystinuria Business (2017-2022)
    Figure 60. Amino GMBH Revenue Growth Rate in Homocystinuria Business (2017-2022)
    Figure 61. KAO Corporation Revenue Growth Rate in Homocystinuria Business (2017-2022)
    Figure 62. DSM Corporation Revenue Growth Rate in Homocystinuria Business (2017-2022)
    Figure 63. Orphan Technologies Revenue Growth Rate in Homocystinuria Business (2017-2022)
    Figure 64. Fresenius Kabi AG Revenue Growth Rate in Homocystinuria Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Market Analysis and Insights: Global and United States Homocystinuria Market
This report focuses on global and United States Homocystinuria market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Homocystinuria market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Diagnosis accounting for % of the Homocystinuria global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Homocystinuria market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Homocystinuria Scope and Market Size
Homocystinuria market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Homocystinuria market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Homocystinuria market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Diagnosis
    Treatment

Segment by Application
    Hospitals
    Clinics
    Diagnostic and Imaging Laboratories
    Academic and Research Institutes
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    BASF SE
    HUAZHONG PHARMACEUTICAL Co. Ltd.
    Pfizer Inc.
    MYLAN N.V.
    Aeglea BioTherapeutics
    Amino GMBH
    KAO Corporation
    DSM Corporation
    Orphan Technologies
    Fresenius Kabi AG